SAN DIEGO, Feb. 17, 2012 /PRNewswire/ -- Synteract, Inc., a full-service contract research organization (CRO), will be hosting limited registration training classes for CDISC, a global, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data. The classes will be held Feb. 21-24, 2012 at Synteract’s Carlsbad, Calif., headquarters.
(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)
CDSIC collaborates with CROs, including Synteract, to develop uniform data standards for clinical trials. Synteract has provided feedback and industry expertise to CDISC during this process as well as assistance with creating uniform data sets that meet the needs of CROs. Synteract, in turn, uses its knowledge of regulatory requirements and standards to guide clients.
The classes will cover CDSIC standards and are appropriate for data management and biostatistics professionals in biotech and pharma companies. The training will be conducted by CDISC teachers and a class list and registration are available on CDISC’s website. Synteract will also be hosting classes for CDISC Aug. 21-24, 2012 at its North Carolina office.
“Synteract is pleased to support CDISC’s mission to improve medical research through platform-independent data standards. Working with CDISC places Synteract at the forefront of industry standards, which we can then pass onto our clients to guide them in the drug development process and ensure data is collected accurately from the start,” explained Stewart Bieler, chief operating officer at Synteract.
Synteract is also assisting with CDASH, a volunteer initiative CDISC began to create a global library of standardized data sets. Synteract currently has three employees contributing to the CDASH project.
About Synteract, Inc. (www.synteract.com)
Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its “Shared Work Shared Vision” philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology.
CONTACT:
Rachel Hutman
Clearpoint Agency, for Synteract
Rachel@clearpointagency.com
760-230-2424
SOURCE Synteract, Inc.
